RANIBIZUMAB (Ongavia®)
Clinical Indication
Age-related macular degeneration, diabetic macular oedema, retinal vein occlusion, Retinopathy of prematurity
Date of classification
August 2022
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.